P2RX5 and breast cancer: The greatest induction of a purinergic receptor upon EMT induction was seen for P2X5, where EGF induced a 4.6-fold increase (Fig. 5B); suggesting that elevated P2X5 may be a characterizing feature of the metastatic phenotype of some breast cancer cells.